Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
iXensor CoROCO:6734 51 14-Day RSI is 48.91 as of Aug. 16, 2026. GuruFocus rates ROCO:6734 with a GF Score™ of 51/100 and a GF Value™ of NT$5.69 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 865 Medical Devices & Instruments companies, iXensor Co ranks better than 61.85% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.
As of today (2026-08-16), iXensor Co's 14-Day RSI is 48.91.
The industry rank for iXensor Co's 14-Day RSI or its related term are showing as below:
ROCO:6734's 14-Day RSI is ranked better than 61.85% of 865
companies
in the Medical Devices & Instruments industry
Industry Median: 52.17
vs ROCO:6734: 48.91
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.
iXensor Co 14-Day RSI Related Terms
ROCO:6734 vs ABT, SYK, MDT: 14-Day RSI Comparison
For the Medical Devices subindustry, iXensor Co's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
iXensor Co 14-Day RSI vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, iXensor Co's 14-Day RSI distribution charts can be found below:
* The bar in red indicates where iXensor Co's 14-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
iXensor Co (ROCO:6734) has a 14-Day RSI of 48.91 as of Aug. 16, 2026. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on iXensor Co and its competitors. According to the industry distribution chart, iXensor Co ranks #330 out of 865 companies in the Medical Devices & Instruments industry, placing it in the top 38.2%.
Is iXensor Co's 14-Day RSI too high?
iXensor Co's current 14-Day RSI is 48.91. The Medical Devices & Instruments industry median 14-Day RSI is 52.17. iXensor Co's value of 48.91 is 6.2% below this industry median. Based on the distribution chart, iXensor Co ranks #330 out of 865 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, iXensor Co has a GF Score™ of 51/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does iXensor Co's 14-Day RSI compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, iXensor Co ranks #330 out of 865 companies for 14-Day RSI. This puts iXensor Co in the upper half of its industry. The industry median 14-Day RSI is 52.17. iXensor Co's value of 48.91 is 6.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 14-Day RSI for a Medical Devices & Instruments company?
The median 14-Day RSI among Medical Devices & Instruments companies is 52.17, based on 865 companies in the industry. Companies in the top quartile (top 25%) have a 14-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 14-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. iXensor Co's current 14-Day RSI of 48.91 is 6.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 14-Day RSI mean?
A high 14-Day RSI can signal that a stock is expensive relative to its fundamentals. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on iXensor Co and its competitors. For the Medical Devices & Instruments industry, the median 14-Day RSI is 52.17 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. iXensor Co's current 14-Day RSI is 48.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is iXensor Co stock overvalued right now?
Based on GuruFocus' analysis, iXensor Co (ROCO:6734) is currently considered Modestly Overvalued. The stock's GF Value™ is NT$5.69, compared to a current price of NT$6.60 — trading 16% above its estimated fair value. The current 14-Day RSI is 48.91 and 6.2% below the Medical Devices & Instruments industry median of 52.17. iXensor Co's overall GF Score™ is 51/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 14-Day RSI calculated?
14-Day RSI is calculated from a company's financial statements. For iXensor Co (ROCO:6734), the current 14-Day RSI is 48.91 as of Aug. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is iXensor Co (ROCO:6734) Overvalued in 2026?
Based on GuruFocus' analysis, iXensor Co stock appears to be overvalued.
The current stock price of NT$6.60 is trading 16% above its estimated GF Value™ of NT$5.69.
GuruFocus considers iXensor Co to be Modestly Overvalued.
Key valuation signals for ROCO:6734:
14-Day RSI: 48.91
GF Value™: NT$5.69 vs. price of NT$6.60 (16% above fair value)
Industry Position: 6.2% below the Medical Devices & Instruments median (#330 of 865)
No single metric tells the full story. See the ROCO:6734 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
iXensor Co Ltd is a Taiwan based company involved in research and development, manufacturing and sales of medical equipment. Its PixoTest technology utilizes the lighting and image sensing module of the smartphone or mobile device to detect the color change reaction on the biochemical test strip. This enables the users to monitor their conditions of diabetes, cardiovascular diseases, women health problems, or infectious diseases.
51GF Score
Get the complete analysis for ROCO:6734
14-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6734 has been successfully added to your 
